The embattled founder of blood testing startup Theranos, Elizabeth Holmes, reportedly still owes her company some $25 million.
That figure was disclosed in a document Theranos was passing around to dissuade investors from suing the company, the Wall Street Journalreported Wednesday, citing people with knowledge of the matter. In return for not suing the company, Holmes would reportedly give the investors part of her personal shares.
According to the WSJ, the debt is the result of an agreement between Holmes and Theranos. Although unclear when the deal was made, it allowed Holmes to exercise her options to buy more shares of the company—though she could also pay at a deferred date.